Sentence examples for a robust panel from inspiring English sources

This paper analyzes a robust, panel style registration data set from 9 outpatient facilities consisting of 5 years of patients' attendance outcomes.

These results underscore the value of combining several promising candidates into a robust panel for CRC detection.

Despite this technical limitation, a robust panel of two putative breast cancer biomarkers was discovered, and verified on an independent sample set.

The identification of a robust panel of CRC-specific biomarkers through genomics would be the cornerstone for their posterior development into non invasive samples-based diagnosis markers.

Admittance into the partnership is based on a robust panel review process that critically assesses a country's ability to administer the financial grant that is awarded from the GPE and to execute the proposed education development strategy.

We have identified a robust panel of commonly differentially expressed genes from 77 normal tissues and 125 cancer samples and demonstrated that these features capture the neoplastic elements of the cancer samples in sufficient detail across many tumor types to provide an accurate diagnostic for cancer detection.

In the end, this three-tiered approach yielded a small, robust panel of type I interferon-inducible mRNAs that could be used in a high-throughput PD biomarker assay to evaluate target inhibition by sifalimumab in SLE trials.

Based on our data, and experience with a range of C. maenas microsatellite markers derived from geographically disparate populations, we anticipate that the combination of the current loci together with those of Tepolt et al. [26] and Darling et al. [13] will facilitate the application of an appropriately robust panel of informative polymorphic markers for population genetic studies.

Combining these with other promising biomarkers may give a robust epigenetic panel with a high sensitivity and specificity for noninvasive CRC detection.

Further studies should include significant numbers of APOE 4/4 and APOE 2/2 samples to create a robust reference panel applicable to any APOE genotype.

Various combinations of markers have been assessed to develop a robust IHC panel for routine pathology reporting, most recently adding Ki67 to ER, PR, HER2 to better assess proliferative luminal tumours (Cheang et al, 2009; Hugh et al, 2009).